Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Taking too many vitamin and mineral supplements can cause serious health problems.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Inositol was not more effective than a placebo in treating trichotillomania.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.